Bourdas DI, Souglis A, Zacharakis ED, Geladas ND, Travlos AK (2021) Meta-analysis of carbohydrate solution intake during prolonged exercise in adults: from the last 45+ years perspective
However, clinical research increasingly recognized that patients with metabolic diseases frequently experience clusters of systemic complications, including heart failure (HF), chronic kidney disease (CKD), and fatty liver disease, that single-target drugs historically failed to address comprehensively
Patients receiving semaglutide 2.4 mg in this trial lost 9.9% of their body weight, compared with 0.4% in those receiving placebo [33]
Most patients receive Lipo-Mino injections once a week, but some may benefit from twice-weekly treatments based on their goals and provider recommendations.